Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness

References

Page 1

	Year	Citations
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Grazia Ambrosini, Colette Adida, Dario C. Altieri Nature Medicine Tumor BiologyOncogenic AgentNovel Anti-apoptosis GeneApoptosisCell Death	1997	3.2K
Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma Holger Moch, Thomas Gasser, Mahul B. Amin, Cancer	2000	481
A role for survivin in chemoresistance of endothelial cells mediated by VEGF Jennifer M. Tran, Zubin Master, Joanne Yu, Proceedings of the National Academy of Sciences	2002	432
Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial Cells Jennifer M. Tran, Janusz Rak, Capucine Sheehan, Biochemical and Biophysical Research Communications AngiogenesisMarked InductionImmunologyEndothelial DysfunctionCell Death	1999	334
Chromophobe Cell Renal Carcinoma: Clinicopathological Features of 50 Cases Thomas B. Crotty, George M. Farrow, Michael M. Lieber The Journal of Urology Cell Renal CarcinomaUrologyRenal FunctionUrologic Cancer EpidemiologyGenitourinary Cancer	1995	270
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Olivier Blanc‐Brude, Mehdi Mesri, Nathan R. Wall, PubMed	2003	213
Fourier analysis of cell motility: correlation of motility with metastatic potential. Alan W. Partin, Joseph S. Schoeniger, James L. Mohler, Proceedings of the National Academy of Sciences Biophysical ModelingFourier Analysis MethodCytoskeletonCell GrowthCellular Physiology	1989	189
Cortactin Overexpression Regulates Actin-Related Protein 2/3 Complex Activity, Motility, and Invasion in Carcinomas with Chromosome 11q13 Amplification B. L. Rothschild, Ann Hye-Ryong Shim, Amanda G. Ammer, Cancer Research Radiation OncologyHnscc CasesCell RegulationHnscc CellsMedicine	2006	162
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1 Bríd M. Ryan, G. Konecny, Steffen Kahlert, Annals of Oncology Urokinase Plasminogen ActivatorBreast OncologyOncologyMedicinePathology	2006	158
Amplification and Overexpression of <i>CTTN</i> ( <i>EMS1</i> ) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance Man‐Li Luo, Xiaoming Shen, Yu Zhang, Cancer Research	2006	154

Page 1